Okla. Stat. tit. 36, § 36-6060.9a

A. 1. Any health benefit plan that provides coverage and

benefits for cancer treatment shall provide coverage of prescribed

orally administered anticancer medications on a basis no less

favorable than intravenously administered or injected cancer

medications.

2. Coverage of orally administered anticancer medication shall

not be subject to any prior authorization, dollar limit, copayment,

deductible, or other out-of-pocket expense that does not apply to

intravenously administered or injected cancer medication, regardless

of formulation or benefit category determination by the company

administering the health benefit plan.

3. A health benefit plan shall not reclassify or increase any

type of cost-sharing to the covered person for anticancer

medications in order to achieve compliance with this section. Any

change in health insurance coverage that otherwise increases an out-

of-pocket expense to anticancer medications shall also be applied to

the majority of comparable medical or pharmaceutical benefits

covered by the health benefit plan.

4. A health benefit plan that limits the total amount paid by a

covered person through all cost-sharing requirements to no more than

One Hundred Dollars ($100.00) per filled prescription for any orally

administered anticancer medication shall be considered in compliance

with this section. For purposes of this paragraph, "cost-sharing

requirements" shall include copayments, coinsurance, deductibles,

and any other amounts paid by the covered person for that

prescription.

B. As used in this section:

1. "Anticancer medications" means medications used to kill or

slow the growth of cancer cells;

2. "Covered person" means a policyholder, subscriber, enrollee,

or other individual enrolled in or insured by a health benefit plan

for health insurance coverage; and

3. "Health benefit plan" means any plan or arrangement as

defined in subsection C of Section 6060.4 of Title 36 of the

Oklahoma Statutes.